SGLT2 inhibitors use tied to lower risk of kidney stones in patients with type 2 diabetes Medha Baranwal31 Jan 2024 11:15 AM ISTUSA: The use of SGLT2 inhibitors in adults with type 2 diabetes (T2D) may lower nephrolithiasis risk compared with GLP-1 receptor agonists or DPP4...
Sclerostin: A key protein for cardiovascular health in patients with type 2 diabetes Niveditha Subramani31 Jan 2024 9:30 AM ISTType 2 diabetes (T2D) is a growing concern as the metabolic disorder is associated with an increased risk of cardiovascular disease (CVD) affecting...
Associations Between Female Reproductive Milestones and Later-life Diabetes and High Cholesterol Risk Niveditha Subramani31 Jan 2024 9:00 AM ISTMetabolic health generally concerns with optimal levels of blood glucose, triglycerides, high-density lipoprotein (HDL) cholesterol, blood pressure,...
Elevated urinary albumin tied to sub-clinical cardiovascular disease in diabetes patients Dr. Kamal Kant Kohli26 Jan 2024 1:45 AM ISTDenmark: A recent study revealed that elevated albumin in the urine may be linked with sub-clinical coronary artery pathology, including coronary...
Diabetes drugs can also reduce the risk of severe liver disease Niveditha Subramani25 Jan 2024 3:56 PM ISTReportedly 80% of patients with liver cirrhosis may have glucose metabolism disorders, 30% show overt diabetes mellitus. Both the metabolic disorder...
Drugs used to treat Type 2 diabetes and obesity may reduce alcohol cravings Dr. Kamal Kant Kohli21 Jan 2024 1:30 AM ISTIn social media posts on the community network Reddit, users reported reduced cravings for alcohol when taking drugs intended to treat Type 2 diabetes...
Healthy lifestyle tied to reduced risk of PAD in genetically susceptible type 2 diabetes patients: Study Medha Baranwal19 Jan 2024 9:00 PM ISTChina: A recent study has shown a lower risk of peripheral artery disease (PAD) among individuals with type 2 diabetes (T2D) with a favourable...
Mazdutide promising GLP-1 and glucagon receptor dual agonist for treating type 2 diabetes: Phase 2 trial Medha Baranwal18 Jan 2024 6:00 AM ISTChina: Findings from a Phase 2 trial have shown an improvement in weight loss and glycemic control with mazdutide use in patients with type 2...
Short-acting GLP-1 receptor agonists may increase risk of GERD in patients with type 2 diabetes: Study Medha Baranwal17 Jan 2024 1:30 AM ISTUSA: A large international propensity score-matched database study has revealed an association between starting shorter-acting glucagon-like peptide-1...
Liraglutide increases insulin sensitivity independent of weight loss in obese diabetics Dr. Kamal Kant Kohli16 Jan 2024 10:00 AM ISTUSA: A recent study published in Diabetes has shown weight loss-independent effect of liraglutide on insulin sensitivity in individuals with obesity...
Loss of cells in pancreas in the elderly may cause age related diabetes Anshika Mishra16 Jan 2024 9:00 AM ISTResearchers from Tokyo Metropolitan University have studied pancreatic islet cell loss in people with no previous pancreatic problems. They identified...
Elevated liver enzyme levels tied to risk of incident type 2 diabetes in obese patients Dr. Shravani Dali6 Jan 2024 10:15 AM ISTAmong obese individuals, elevated liver enzyme levels tied to risk for incident type 2 diabetes suggests a new study published in the Acta...
